Honn K V, Timár J, Rozhin J, Bazaz R, Sameni M, Ziegler G, Sloane B F
Department of Radiation Oncology, Wayne State University, Detroit, Michigan 48202.
Exp Cell Res. 1994 Sep;214(1):120-30. doi: 10.1006/excr.1994.1240.
The process of tumor cell invasion of the basement membrane is proposed to consist of three steps: attachment, local proteolysis and migration. 12-(S)-HETE, a 12-lipoxygenase metabolite of arachidonic acid, upregulates surface expression of integrin cytoadhesins and an autocrine motility factor receptor, suggesting that this metabolite may play an important regulatory function in tumor cell invasion. In the present study, we determined whether 12-(S)-HETE affects surface expression and/or release of cathepsin B, a cysteine protease that has been implicated in focal degradation of basement membrane. Secretion and distribution of cathepsin B was evaluated in two model systems for various stages of neoplastic progression: (i) murine B16 melanoma lines of low (B16-F1) and high (B16a) lung colonization potential, and (ii) immortalized and ras-transfected MCF-10 human breast epithelial cells that differ in their invasive capacities in vitro. In the B16a cells, 12-(S)-HETE induced release of native and latent cathepsin B activity and concomitantly reduced cell-associated cathepsin B immunoreactivity. In contrast, 12-(S)-HETE did not induce the release of cathepsin B from B16-F1 cells, suggesting that there may be an enhanced response to 12-(S)-HETE in more malignant cells. This was confirmed in the MCF-10 system, in which 12-(S)-HETE was able to induce the release of cathepsin B from the ras-transfected cells, but not from the immortal cells. A simultaneous reduction in staining for cathepsin B was observed in the ras-transfected cells, but not in their immortal counterparts. The release of cathepsin B may be mediated by PKC as pretreatment of B16a cells with the selective PKC inhibitor calphostin C, but not with the PKA inhibitor H8, prevented the stimulated release of cathepsin B. In B16a cells, the release of cathepsin B was accompanied by a translocation toward the cell periphery of vesicles staining for cathepsin B, resulting in focal areas of accumulation of cathepsin B. After 12-(S)-HETE stimulation of the ras-transfected MCF-10 cells, cathepsin B was distributed homogeneously on the apical surface. Thus, 12-(S)-HETE can upregulate the surface expression on tumor cells of proteins able to mediate each of the three steps of tumor cell invasion: adhesion, degradation, and migration.
附着、局部蛋白水解和迁移。12-(S)-HETE是花生四烯酸的12-脂氧合酶代谢产物,它上调整合素细胞粘附素和自分泌运动因子受体的表面表达,这表明该代谢产物可能在肿瘤细胞侵袭中发挥重要的调节作用。在本研究中,我们确定了12-(S)-HETE是否影响组织蛋白酶B的表面表达和/或释放,组织蛋白酶B是一种与基底膜局灶性降解有关的半胱氨酸蛋白酶。在肿瘤进展不同阶段的两个模型系统中评估了组织蛋白酶B的分泌和分布:(i)具有低(B16-F1)和高(B16a)肺定植潜能的小鼠B16黑色素瘤细胞系,以及(ii)在体外侵袭能力不同的永生化和ras转染的MCF-10人乳腺上皮细胞。在B16a细胞中,12-(S)-HETE诱导天然和潜在的组织蛋白酶B活性释放,并同时降低细胞相关的组织蛋白酶B免疫反应性。相反,12-(S)-HETE未诱导B16-F1细胞释放组织蛋白酶B,这表明在恶性程度更高的细胞中可能对12-(S)-HETE有增强的反应。这在MCF-10系统中得到证实,在该系统中,12-(S)-HETE能够诱导ras转染细胞释放组织蛋白酶B,但不能诱导永生化细胞释放。在ras转染细胞中观察到组织蛋白酶B染色同时减少,但在其永生化对应细胞中未观察到。组织蛋白酶B的释放可能由蛋白激酶C介导,因为用选择性蛋白激酶C抑制剂钙泊三醇C预处理B16a细胞可阻止组织蛋白酶B的刺激释放,而用蛋白激酶A抑制剂H8预处理则不能。在B16a细胞中,组织蛋白酶B的释放伴随着对组织蛋白酶B染色的囊泡向细胞周边的转位,导致组织蛋白酶B的局部聚集区域。在对ras转染的MCF-10细胞进行12-(S)-HETE刺激后,组织蛋白酶B均匀分布在顶端表面。因此,12-(S)-HETE可以上调肿瘤细胞表面能够介导肿瘤细胞侵袭三个步骤(粘附、降解和迁移)中每一步的蛋白质的表达。